The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2016 | Improved outcomes in leukemia, trauma settings with personalized medicine approaches
At a press conference during the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA, Mikkael Sekeres, MD, MS, Cleveland Clinic, Cleveland, OH, introduces the press briefing on ‘Improved outcomes in leukemia, trauma settings with personalized medicine approaches’.
